The Life Length Telomere Analysis Technology (TAT) will become a key test of age management, raising the bar of a proactive, preventive medical approach.
Las Vegas, NV (PRWEB) February 08, 2012
Life Length®, the leading telomere testing and services company, announced an agreement with Cenegenics® Medical Institute to offer the test to its more than 20,000 patients—including 2,000 doctors and their families—through its nationwide network of 19 facilities and 100 physician affiliates.
Stephen J. Matlin, CEO, Life Length said, “We are delighted to partner with Cenegenics, the world’s largest age management practice and recognized leading authority in their field, helping patients age healthily through proactive, preventive medicine. Life Length’s test will help raise the bar further since telomeres are best predictors of biological age and excellent general health indicators. Through Cenegenics, the Life Length Telomere Analysis Technology (TAT) will become a key test of age management.”
Dr. Robert D. Willix, Jr., Cenegenics’ Chief Medical Officer, noted, “We are pleased to partner with Life Length to provide extremely accurate analyses of critically short telomeres, those primarily responsible for aging and age-related diseases. We will encourage all our patients to be tested regularly to assess one of the best biomarkers and determine their biological versus chronological age.The test will expand a patient’s health evaluation and take it to the next level.”
A bout Life Length
Life Length, a life sciences company founded in 2010 to commercially exploit TAT developed by Dr. Maria Blasco, Chief Scientific Advisor, Life Length and Director, Spanish National Cancer Research Centre, provides testing services to pharmaceutical and biotech industries for drug R&D and clinical trials, as well as to the general public through physicians and clinics interested in telomere indicators of biological age and overall health. Life Length is the first company offering such precise testing. The founding partners are the Botin Foundation, Dr. Blasco and Matlin Associates.
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Cenegenics has 19 centers with others opening in the near future: Las Vegas, Nevada (headquarters); Charleston, SC; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston, TX; Denver, CO; Scottsdale, AZ; Boston, MA. Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families.